Evidence map›Paper›PMID 32487471›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2020

Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.

Chen Yang Kevin Zhang, Musawir Ahmed, Ella Huszti, Liran Levy, Sarah E Hunter, Kristen M Boonstra, Sajad Moshkelgosha, Andrew T Sage, Sassan Azad, Ricardo Zamel and 16 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. The prognostic value of single and repeated ≥10% FEVThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Lung Allograft Dysfunction: Does Aspiration Hold the Key?American journal of respiratory and critical care medicine · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Aspiration of conjugated bile acids predicts adverse lung transplant outcomes and correlates with airway lipid and cytokine dysregulation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 2 countries.

Chen Yang Kevin ZhangToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Musawir AhmedToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Ella HusztiBiostatistics Research Unit, University Health Network, Toronto, Ontario, Canada.
Liran LevyToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Sarah E HunterToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Kristen M BoonstraToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Sajad MoshkelgoshaToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Andrew T SageToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Sassan AzadToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Ricardo ZamelToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Rasheed GhanyToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Jonathan C YeungToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Oscar M CrespinDivision of General Surgery, University Health Network, University of Toronto, Toronto, Canada.
Courtney FrankelDuke University Medical Center, Durham, North Carolina.
Marie BudevCleveland Clinic, Cleveland, Ohio.
Pali ShahJohns Hopkins University Hospital, Baltimore, Maryland.
John M ReynoldsDuke University Medical Center, Durham, North Carolina.
Laurie D SnyderDuke University Medical Center, Durham, North Carolina.
John A BelperioUCLA Medical Center, Los Angeles, California.
Lianne G SingerToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
S Samuel WeigtUCLA Medical Center, Los Angeles, California.
Jamie L ToddDuke University Medical Center, Durham, North Carolina.
Scott M PalmerDuke University Medical Center, Durham, North Carolina.
Shaf KeshavjeeToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada.
Tereza MartinuToronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada. Electronic address: tereza.martinu@uhn.ca.
CTOT-20 investigators
University Health Network · CADuke Medical Center · USCleveland Clinic · USJohns Hopkins University · USRonald Reagan UCLA Medical Center · USUCLA Medical Center · US

Funding

The Lung Transplant Clinical Trials Network (LT-CTN)U01AI113315 · NIAID · DUKE UNIVERSITY · PI PALMER, SCOTT M · 2014 to 2018
$12.9M
NIAID NIH HHS U01 AI113315
6 · The paper itself

Abstract

backgroundGastroesophageal reflux disease (GERD) is a risk factor for chronic lung allograft dysfunction. Bile acids-putative markers of gastric microaspiration-and inflammatory proteins in the bronchoalveolar lavage (BAL) have been associated with chronic lung allograft dysfunction, but their relationship with GERD remains unclear. Although GERD is thought to drive chronic microaspiration, the selection of patients for anti-reflux surgery lacks precision. This multicenter study aimed to test the association of BAL bile acids with GERD, lung inflammation, allograft function, and anti-reflux surgery.

methodsWe analyzed BAL obtained during the first post-transplant year from a retrospective cohort of patients with and without GERD, as well as BAL obtained before and after Nissen fundoplication anti-reflux surgery from a separate cohort. Levels of taurocholic acid (TCA), glycocholic acid, and cholic acid were measured using mass spectrometry. Protein markers of inflammation and injury were measured using multiplex assay and enzyme-linked immunosorbent assay.

resultsAt 3 months after transplantation, TCA, IL-1β, IL-12p70, and CCL5 were higher in the BAL of patients with GERD than in that of no-GERD controls. Elevated TCA and glycocholic acid were associated with concurrent acute lung allograft dysfunction and inflammatory proteins. The BAL obtained after anti-reflux surgery contained reduced TCA and inflammatory proteins compared with that obtained before anti-reflux surgery.

conclusionsTargeted monitoring of TCA and selected inflammatory proteins may be useful in lung transplant recipients with suspected reflux and microaspiration to support diagnosis and guide therapy. Patients with elevated biomarker levels may benefit most from anti-reflux surgery to reduce microaspiration and allograft inflammation.

Indexed as

Lung TransplantationTransplant RecipientsAdultAgedBile Acids and SaltsBiomarkersBronchiolitis ObliteransBronchoalveolar Lavage FluidFemaleFollow-Up StudiesGastroesophageal RefluxGraft RejectionHumansMaleMiddle AgedRetrospective StudiesBile Acids and SaltsBiomarkersbile acidbiomarkersgastroesophageal reflux diseaseinflammationlung transplantation

Identifiers

PMID32487471
PMCPMC7483994
OpenAlexW3026843533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.